← back to search

Xiaoqing Xu

Harbin Medical University · CN
Area of research
Public Health, Environmental and Occupational Health · Cancer Research
Research interest
Research interests include Medicine, Internal medicine, National Health and Nutrition Examination Survey, Disease, Folic acid, and Breast cancer.
h-index
citations
320
works
9
NIH funding
primary concept
email

Recent publications

Associations of meeting the 24-hour movement behaviors guidelines with emotional, social, and academic function among children and adolescents with hearing loss: findings from the 2018–2022 national survey of children’s health in the U.S.
BMC Public Health 2025cited by 3position: middledoi
Relationship of dietary natural folate and synthetic folic acid co-exposure patterns with biological aging: findings from NHANES 2003–2018
Food & Function 2024cited by 5position: middledoi
Association of Dietary Inflammatory Index and Dietary Oxidative Balance Score with All-Cause and Disease-Specific Mortality: Findings of 2003–2014 National Health and Nutrition Examination Survey
Nutrients 2023cited by 57position: middledoi
Association of plasma branched-chain amino acid with multiple cancers: A mendelian randomization analysis
Clinical Nutrition 2023cited by 25position: middledoi
Association of folate intake with cardiovascular-disease mortality and all-cause mortality among people at high risk of cardiovascular-disease
Clinical Nutrition 2021cited by 29position: firstdoi
The association of minerals intake in three meals with cancer and all-cause mortality: the U.S. National Health and Nutrition Examination Survey, 2003–2014
BMC Cancer 2021cited by 22position: firstdoi
Dibromoacetic acid exposure is associated with abnormal melatonin rhythm in rats via inhibition of p-CREB1-AANAT signalling pathway
Ecotoxicology and Environmental Safety 2020cited by 4position: middledoi
Cardiovascular disease risk and androgen deprivation therapy in patients with localised prostate cancer: a prospective cohort study
British Journal of Cancer 2017cited by 73position: middledoi
Cardiovascular Disease After Aromatase Inhibitor Use
JAMA Oncology 2016cited by 102position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ying Li · Jiangsu University6 papers (2020–2024)Wenbo Jiang · Xihua University3 papers (2020–2021)Wei Wei · Guangxi Medical University2 papers (2021–2021)Yuntao Zhang · Zhejiang University of Science and Technology2 papers (2023–2023)Xuemin Yan · Harbin Medical University2 papers (2020–2023)Changhao Sun · Zhongyuan University of Technology2 papers (2020–2021)Xuanyang Wang · Harbin Medical University2 papers (2023–2023)Tianshu Han · Harbin Medical University2 papers (2020–2021)Keke Dang · Harbin Medical University2 papers (2023–2023)Reina Haque · Kaiser Permanente2 papers (2016–2017)Yunyan Chen · South China Agricultural University1 papers (2021–2021)Jiaxin Huang · Sun Yat-sen University Cancer Center1 papers (2021–2021)Licheng Cheng · Harbin Medical University1 papers (2023–2023)Xin Liu · Fujian Medical University1 papers (2020–2020)Li Li · Xiamen University1 papers (2021–2021)Yue Wang · South China Agricultural University1 papers (2020–2020)Hongmei Wu · Nantong University1 papers (2025–2025)Pei Zhang · University of Helsinki1 papers (2025–2025)Yu Wang · Harbin Medical University1 papers (2020–2020)Huan Xu · Harbin Medical University1 papers (2023–2023)